PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAF1. A total of 31 filers reported holding PDL BIOPHARMA INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $218,000 | +1.4% | 218,000 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $215,000 | +1.4% | 218,000 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $212,000 | 0.0% | 218,000 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $212,000 | +2.4% | 218,000 | 0.0% | 0.00% | -20.0% |
Q2 2016 | $207,000 | +18.3% | 218,000 | 0.0% | 0.01% | +25.0% |
Q4 2015 | $175,000 | -8.9% | 218,000 | 0.0% | 0.00% | -20.0% |
Q3 2015 | $192,000 | -7.2% | 218,000 | 0.0% | 0.01% | 0.0% |
Q2 2015 | $207,000 | – | 218,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pinnacle Summer Investments, Inc. | 1,193,517 | $41,614,000 | 5.12% |
BASSO CAPITAL MANAGEMENT, L.P. | 13,943,000 | $13,612,000 | 2.17% |
SILVERBACK ASSET MANAGEMENT LLC | 8,000,000 | $7,816,000 | 1.01% |
GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,100,000 | $7,863,000 | 0.80% |
ZAZOVE ASSOCIATES LLC | 13,180,000 | $12,725,000 | 0.52% |
LINDEN ADVISORS LP | 2,743,000 | $2,658,000 | 0.50% |
IRON Financial LLC | 390,000 | $3,729,000 | 0.38% |
ADVENT CAPITAL MANAGEMENT /DE/ | 25,114,000 | $24,280,000 | 0.36% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 26,500,000 | $25,341,000 | 0.32% |
WOLVERINE ASSET MANAGEMENT LLC | 11,936,000 | $11,574,000 | 0.22% |